Incidental Cholangiocarcinoma Diagnosed in Explanted Livers: A Single Center Experience

authors:

avatar Bita Geramizadeh 1 , 2 , * , avatar Mohammad Baghernezhad 3

Department of Pathology, Shiraz University of Medical Sciences, Shiraz, Iran
Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Organ Transplantation and Hepatobiliary Surgery Center, Shiraz University of Medical Sciences, Shiraz, Iran
Hepatitis Monthly: Vol.17, issue 7; e57195
published online: July 9, 2017
article type: Letter
received: July 1, 2017
accepted: July 22, 2017
DOI: https://doi.org/10.5812/hepatmon.57195

how to cite: Geramizadeh B, Baghernezhad M. Incidental Cholangiocarcinoma Diagnosed in Explanted Livers: A Single Center Experience. Hepat Mon. 2017;17(7):e57195. https://doi.org/10.5812/hepatmon.57195.

Acknowledgements

References

  • 1.

    Ghali P, Marotta PJ, Yoshida EM, Bain VG, Marleau D, Peltekian K, et al. Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience. Liver Transpl. 2005;11(11):1412-6. [PubMed ID: 16237695]. https://doi.org/10.1002/lt.20512.

  • 2.

    Takahashi K, Obeid J, Burmeister CS, Bruno DA, Kazimi MM, Yoshida A, et al. Intrahepatic Cholangiocarcinoma in the Liver Explant After Liver Transplantation: Histological Differentiation and Prognosis. Ann Transplant. 2016;21:208-15. [PubMed ID: 27068242]. https://doi.org/10.12659/AOT.895936.

  • 3.

    Geramizadeh B, Ghavvas R, Kazemi K, Shamsaeefar A, Nikeghbalian S, Malekhosseini SA. Cholangiocarcinoma Secondary to Primary Sclerosing Cholangitis in Explanted Livers: A Single-Center Study in the South of Iran. Hepat Mon. 2015;15(12). e33626. [PubMed ID: 26977169]. https://doi.org/10.5812/hepatmon.33626.